Relay Therapeutics (RLAY) Preferred Shares (2019)

Relay Therapeutics (RLAY) reported Preferred Shares of $537.8 million for Q4 2019.

Relay Therapeutics (RLAY) Preferred Shares (2019) Analysis & Trends

Relay Therapeutics (RLAY) has 1 years of Preferred Shares data on file, last reported at $537.8 million in Q4 2019.

Preferred Shares for Q4 2019 came in at $537.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $537.8 million (changed N/A YoY), and the FY2019 annual result was $537.8 million, changed N/A from the prior year.
Preferred Shares steadied at $537.8 million in Q4 2019 per RLAY's latest filing.
Over five years, Preferred Shares peaked at $537.8 million in Q4 2019 and troughed at $537.8 million in Q4 2019.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Relay Therapeutics	2.86 Bn	2.86 Bn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2019	537.78 Mn